See the original post: Homology Medicines Declares Distribution to Common Stockholders
See the original post: Homology Medicines Declares Distribution to Common Stockholders
View post: Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
Originally posted here: Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
Read the original: Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million
Follow this link: QDOSE® Platform Partnership for Personalized Dosimetry in Radiopharmaceutical Therapy
Originally posted here: BioXcel Therapeutics Announces European Patent Office’s Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual...
Read more: Mendus’ major shareholders and members of the Board of Directors and Management declare their intention to exercise warrants of series TO3
Read the rest here: University of Calgary Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
More here: Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
Read more here: Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8®
Recent Comments